1. Home
  2. HAE vs WNS Comparison

HAE vs WNS Comparison

Compare HAE & WNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • WNS
  • Stock Information
  • Founded
  • HAE 1971
  • WNS 1996
  • Country
  • HAE United States
  • WNS India
  • Employees
  • HAE N/A
  • WNS N/A
  • Industry
  • HAE Medical/Dental Instruments
  • WNS Business Services
  • Sector
  • HAE Health Care
  • WNS Consumer Discretionary
  • Exchange
  • HAE Nasdaq
  • WNS Nasdaq
  • Market Cap
  • HAE 3.3B
  • WNS 3.2B
  • IPO Year
  • HAE 1991
  • WNS N/A
  • Fundamental
  • Price
  • HAE $54.56
  • WNS $75.49
  • Analyst Decision
  • HAE Buy
  • WNS Hold
  • Analyst Count
  • HAE 11
  • WNS 9
  • Target Price
  • HAE $86.73
  • WNS $67.67
  • AVG Volume (30 Days)
  • HAE 1.3M
  • WNS 639.9K
  • Earning Date
  • HAE 08-07-2025
  • WNS 10-16-2025
  • Dividend Yield
  • HAE N/A
  • WNS N/A
  • EPS Growth
  • HAE 46.89
  • WNS 21.19
  • EPS
  • HAE 3.28
  • WNS 3.60
  • Revenue
  • HAE $1,346,046,000.00
  • WNS $1,345,621,000.00
  • Revenue This Year
  • HAE N/A
  • WNS $7.23
  • Revenue Next Year
  • HAE $6.50
  • WNS $9.29
  • P/E Ratio
  • HAE $16.62
  • WNS $21.00
  • Revenue Growth
  • HAE 0.91
  • WNS 1.94
  • 52 Week Low
  • HAE $50.68
  • WNS $42.62
  • 52 Week High
  • HAE $94.99
  • WNS $75.67
  • Technical
  • Relative Strength Index (RSI)
  • HAE 33.12
  • WNS 75.86
  • Support Level
  • HAE $53.90
  • WNS $75.39
  • Resistance Level
  • HAE $56.64
  • WNS $75.58
  • Average True Range (ATR)
  • HAE 1.64
  • WNS 0.22
  • MACD
  • HAE 0.46
  • WNS -0.24
  • Stochastic Oscillator
  • HAE 65.10
  • WNS 86.57

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)

WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.

Share on Social Networks: